isothiuronium has been researched along with fluorescein-5-isothiocyanate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Shimon, M; Goldshleger, R; Hoving, S; Karlish, SJ; Tal, DM; Tijmes, JJ | 1 |
| Chen, LW; Hsu, CM; Liu, CH | 1 |
2 other study(ies) available for isothiuronium and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Novel aromatic isothiouronium derivatives which act as high affinity competitive antagonists of alkali metal cations on Na/K-ATPase.
Topics: Animals; Binding, Competitive; Cations, Monovalent; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Isothiuronium; Kidney Medulla; Kinetics; Molecular Structure; Protein Conformation; Rubidium; Sodium; Sodium-Potassium-Exchanging ATPase; Spectrometry, Fluorescence; Structure-Activity Relationship | 1995 |
Nitric oxide synthase inhibitor ameliorates oral total parenteral nutrition-induced barrier dysfunction.
Topics: Administration, Oral; Animals; Atrophy; Bacterial Translocation; Dextrans; Enzyme Activation; Enzyme Inhibitors; Female; Fluorescein-5-isothiocyanate; Ileum; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Isothiuronium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Parenteral Nutrition, Total; Permeability; Rats; Rats, Sprague-Dawley; Solutions | 2000 |